Engineering ARMMs for improved intracellular delivery of CRISPR-Cas9
CRISPR-Cas9-based gene editing holds enormous promise for therapeutic applications, but its effectiveness is often limited by inefficient delivery methods. This study explores the potential of arrestin domain-containing protein 1 (ARRDC1)-mediated microvesicles (ARMMs)—a type of extracellular vesicl...
Saved in:
| Main Authors: | Zunwei Chen, Qiyu Wang, Quan Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Extracellular Vesicle |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2773041725000186 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>Macrobrachium rosenbergii</i> Genome Editing Breeding with CRISPR–Cas Nucleases, Base Editors, and Prime Editors
by: Guo Li, et al.
Published: (2025-07-01) -
Arrestin domain-containing protein 1-mediated microvesicles (ARMMs) protect against cadmium-induced neurotoxicity
by: Zunwei Chen, et al.
Published: (2023-12-01) -
Direct delivery of Cas9 or base editor protein and guide RNA complex enables genome editing in the retina
by: Juliette Pulman, et al.
Published: (2024-12-01) -
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
by: Xinmei Liu, et al.
Published: (2025-04-01) -
Genetic engineering in oncology based on CRISPR-Cas9 technology
by: D. Sh. Polatova, et al.
Published: (2024-09-01)